MTARC1 and Hepatic steatosis: Global genetic deletion and hepatocyte-specific knockdown of mARC1 in mice significantly reduced liver steatosis and fibrosis in multiple mouse models of metabolic dysfunction–associated steatohepatitis and liver fibrosis.